Literature DB >> 14697202

An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR.

Christoph Randak1, Michael J Welsh.   

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel in the ATP binding cassette (ABC) transporter family. Like other ABC transporters, it can hydrolyze ATP. Yet while ATP hydrolysis influences channel gating, it has long seemed puzzling that CFTR would require this reaction because anions flow passively through CFTR. Moreover, no other ion channel is known to require the large energy of ATP hydrolysis to gate. We found that CFTR also has adenylate kinase activity (ATP + AMP <=> ADP + ADP) that regulates gating. When functioning as an adenylate kinase, CFTR showed positive cooperativity for ATP suggesting its two nucleotide binding domains may dimerize. Thus, channel activity could be regulated by two different enzymatic reactions, ATPase and adenylate kinase, that share a common ATP binding site in the second nucleotide binding domain. At physiologic nucleotide concentrations, adenylate kinase activity, rather than ATPase activity may control gating, and therefore involve little energy consumption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14697202     DOI: 10.1016/s0092-8674(03)00983-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  20 in total

1.  Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.

Authors:  Allan L Berger; Mutsuhiro Ikuma; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

2.  Physiological and pharmacological characterization of the N1303K mutant CFTR.

Authors:  Samantha DeStefano; Maarten Gees; Tzyh-Chang Hwang
Journal:  J Cyst Fibros       Date:  2018-06-07       Impact factor: 5.482

3.  A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating.

Authors:  Qian Dong; Christoph O Randak; Michael J Welsh
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

4.  Dynamic expression of adenylate kinase 2 in the hippocampus of pilocarpine model rats.

Authors:  Xi Peng; Liang Wang; Guojun Chen; Xuefeng Wang
Journal:  J Mol Neurosci       Date:  2012-01-14       Impact factor: 3.444

Review 5.  NM23 proteins: innocent bystanders or local energy boosters for CFTR?

Authors:  Richmond Muimo; Hani Mm Alothaid; Anil Mehta
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

Review 6.  Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.

Authors:  Ronald C Rubenstein
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

7.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

8.  Development of a porcine model of cystic fibrosis.

Authors:  Michael J Welsh; Christopher S Rogers; David A Stoltz; David K Meyerholz; Randall S Prather
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

9.  Chimeric constructs endow the human CFTR Cl- channel with the gating behavior of murine CFTR.

Authors:  Toby S Scott-Ward; Zhiwei Cai; Elizabeth S Dawson; Ann Doherty; Ana Carina Da Paula; Heather Davidson; David J Porteous; Brandon J Wainwright; Margarida D Amaral; David N Sheppard; A Christopher Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

Review 10.  Role of CFTR's intrinsic adenylate kinase activity in gating of the Cl(-) channel.

Authors:  Christoph O Randak; Michael J Welsh
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.